封面
市場調查報告書
商品編碼
2018658

醫用氧氣濃縮機和氧氣瓶市場:2026年至2032年全球市場預測(按產品類型、流量類型、技術、應用、最終用戶和分銷管道分類)

Medical Oxygen Concentrators & Oxygen Cylinders Market by Product Type, Flow Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,醫用氧氣濃縮機和氧氣瓶市場價值將達到 40.1 億美元,到 2026 年將成長至 43.5 億美元,到 2032 年將達到 73.9 億美元,複合年成長率為 9.14%。

主要市場統計數據
基準年 2025 40.1億美元
預計年份:2026年 43.5億美元
預測年份 2032 73.9億美元
複合年成長率 (%) 9.14%

從策略角度概述了設備創新、不斷發展的醫療保健服務和採購重點如何重塑臨床和家庭環境中的氧氣輸送選擇。

醫用氧氣輸送生態系統發展迅速,涵蓋了多種技術、輸送方式和臨床應用場景,其發展受到人口結構變化、組件設計進步以及對穩健供應鏈的重新重視等因素的影響。雖然鋼瓶等加壓解決方案在急診醫學和高流量重症監護中仍然至關重要,但電動制氧機平台正日益取代一次性氧氣輸送模式,應用於居家照護和門診治療。同時,攜帶式製氧機在電池性能、流量控制和用戶操作方面也在不斷改進,從而提高了患者的活動能力和門診治療依從性。

技術小型化、數位化融合以及分銷模式的改變,正在如何重塑氧氣供應領域的競爭格局和臨床應用路徑?

氧氣輸送領域經歷了變革性的轉變,這得益於技術的微型化、材料的改進以及強調連續性和便攜性的新型服務模式。變壓式吸附模組和薄膜材料的進步提高了氧氣純度和能源效率,使得小型、低維護的固定式裝置和運作時間更長的攜帶式製氧機成為可能。這些進步正在加速長期氧氣療法在居家照護中的廣泛應用,同時又不影響臨床安全性和患者的活動能力。

評估美國關稅調整對整個氧氣供應鏈的籌資策略、製造地決策以及臨床連續性考量的影響。

關稅的引入或調整將對氧氣供應設備的零件採購、製造地和定價策略產生重大影響。當關鍵子組件和成品被徵收進口關稅時,製造商通常會採取的應對措施包括:尋找替代供應商、轉移組裝流程,或根據合約條款和競爭壓力,選擇性地將新增成本轉嫁給買方,而自身則承擔這些成本。這些商業應對措施可能會改變補貨前置作業時間,並重組與供應商的關係,因為採購團隊需要以可接受的總擁有成本尋求可預測的供應。

將產品類型、流程特性、技術平台、通路、臨床應用和最終用戶操作要求連結起來的綜合細分洞察。

為了分析需求和部署模式,必須考慮不同產品類型和技術特性如何滿足臨床需求和營運限制。氧氣瓶在急診醫學和重症監護中仍然發揮著至關重要的作用,在這些領域,高壓儲存和便攜性對於滿足即時高流量需求至關重要。固定式和攜帶式製氧機分別適用於不同的護理模式。固定式製氧機滿足診所和多病房設施中持續供氧的需求,而攜帶式製氧機則使患者能夠行走並繼續進行門診治療。此外,流量特性也決定了設備的適用性。持續供氧系統通常適用於需要穩定供氧的患者,而脈衝式製氧機則針對間歇性呼吸供氧進行了最佳化,以提高電池壽命和縮小體積。

區域觀點下的基礎設施發展、監管預期和供應鏈調整如何影響全球主要市場的設備選擇和服務交付。

區域趨勢決定了法律規範、報銷機制和供應鏈結構,這些因素共同影響產品的供應和採購行為。在美洲,完善的臨床標準和健全的居家醫療基礎設施支援固定式和攜帶式氧氣濃縮機的廣泛應用,而物流網路和服務供應商優先考慮快速回應和覆蓋範圍。貿易政策和對國內製造業的獎勵影響供應商的策略,而都市區在醫療資源取得方面的差距則持續推動著攜帶式解決方案的創新。

競爭格局和供應商趨勢強調整合服務解決方案、多元化供應鏈以及零件和利基設備功能的專業化。

主要企業和創新新興企業正透過提高能源效率、降低噪音和改進用戶介面來提升產品差異化,從而簡化維護和臨床醫生監控。設備製造商和服務供應商之間的策略合作夥伴關係日益普遍,將設備供應與遙測驅動的維護合約和耗材補充計劃相結合。這種向結果導向商業模式的轉變反映了更廣泛的行業趨勢:買家越來越重視可預測的正常運作和貫穿整個生命週期的支持,而不僅僅是一次性資本投入。

為高階主管提供切實可行的策略,以提高產品適應性、區域供應彈性、混合分銷的有效性以及以臨床醫生為中心的服務模式。

產業領導者應優先考慮多方面的韌性策略,在產品創新與切實可行的供應鏈風險管理之間取得平衡。首先,加快產品模組化和替代零件設計的實踐,以便在確保符合監管要求和臨床性能的前提下,快速替換受關稅影響的組件。其次,投資於可靠的本地夥伴關係關係和區域組裝能力,以縮短前置作業時間並降低跨境中斷帶來的風險。第三,將遠端監控功能和預測性維護工具整合到新一代醫療設備中,以提高運轉率並創造業務收益來源,從而抵消資本負擔。

描述了一種混合方法研究途徑,該方法結合了實地訪談、醫療設備性能觀察、監管分析和基於場景的檢驗。

本研究採用定性和定量相結合的調查方法,以確保獲得可靠且多方驗證的證據基礎,同時尊重商業參與者的保密要求。主要研究包括對醫院、診所和居家照護機構的臨床醫生、採購負責人、醫療設備工程師和供應鏈經理進行結構化訪談,以了解其營運實踐、臨床重點以及影響採購決策的因素。現場考察和醫療設備性能觀察補充了訪談所得信息,從而檢驗了運作、維護頻率和用戶人體工學方面的相關說法。

簡潔扼要的結論指出,在所有護理環境中,要維持可靠的氧氣輸送,必須落實技術、增強供應韌性並加強協作。

總而言之,氧氣供應產業正處於轉折點,漸進式技術進步與不斷變化的護理模式和供應鏈現實交織在一起。兼具臨床可靠性、能源效率和遠端系統管理功能的設備能夠很好地滿足醫院、診所和家庭環境中日益成長的持續護理需求。將強大的本地服務網路與便利的線上支援結合的分銷策略,既能擴大服務範圍,又能保持支援品質。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章 醫用氧氣濃縮機和氧氣瓶市場:依產品類型分類

  • 氧氣罐
  • 攜帶式醫用氧氣濃縮機和氧氣瓶
  • 固定式醫用氧氣濃縮機和氧氣瓶

第9章:依流量類型分類的醫用氧氣濃縮機和氧氣瓶市場

  • 連續流速
  • 脈衝給藥

第10章 醫用氧氣濃縮機和氧氣瓶市場:依技術分類

  • 膜技術
  • 變壓式吸附

第11章 醫用氧氣濃縮機和氧氣瓶市場:按應用領域分類

  • 慢性病護理
  • 重症監護
  • 緊急使用

第12章 醫用氧氣濃縮機和氧氣瓶市場:依最終用戶分類

  • 診所
  • 居家照護
  • 醫院

第13章 醫用氧氣濃縮機和氧氣瓶市場:依通路分類

  • 實體店面
  • 線上零售

第14章 醫用氧氣濃縮機和氧氣瓶市場:依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 醫用氧氣濃縮機和氧氣瓶市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 醫用氧氣濃縮機和氧氣瓶市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章:美國醫用氧氣濃縮機和氧氣瓶市場

第18章:中國醫用氧氣濃縮機和氧氣瓶市場

第19章 競爭情勢

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Air Products Inc.
  • AMS Composite Cylinders
  • ARYA BioMed Corp.
  • Caire Inc. by Niterra Group
  • Chaban Medical Ltd.
  • Cobham Limited
  • DeVilbiss Healthcare GmbH
  • GCE Group AB
  • GPC Medical Ltd.
  • GVS SpA
  • Inogen Inc.
  • Invacare Corporation
  • Koninklijke Philips NV
  • Linde PLC
  • Luxfer Gas Cylinders
  • Microteck Systems & Solution
  • Narang Medical Limited
  • Nidek Medical Products, Inc.
  • O2 Concepts, LLC
  • OxyGo, LLC
  • OxyMed
  • ResMed Inc.
  • Silverline Meditech Pvt. Ltd.
  • VARON
  • VitalAire Canada Inc.
  • WEINMANN Emergency Medical Technology GmbH+Co. KG
  • Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
Product Code: MRR-221461477235

The Medical Oxygen Concentrators & Oxygen Cylinders Market was valued at USD 4.01 billion in 2025 and is projected to grow to USD 4.35 billion in 2026, with a CAGR of 9.14%, reaching USD 7.39 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.01 billion
Estimated Year [2026] USD 4.35 billion
Forecast Year [2032] USD 7.39 billion
CAGR (%) 9.14%

A strategic overview of how device innovation, care delivery evolution, and procurement priorities are reshaping oxygen delivery choices across clinical and home settings

The medical oxygen delivery ecosystem encompasses a diverse set of technologies, delivery formats, and clinical use cases that have evolved rapidly under the influence of demographic shifts, advances in component design, and renewed emphasis on resilient supply chains. Pressure-driven solutions such as cylinders remain essential for emergency and high-flow critical care, while electrically powered concentrator platforms increasingly displace disposable supply models in home care and ambulatory settings. Concurrently, portable concentrators have improved battery performance, flow modulation and user ergonomics, which together expand patient mobility and outpatient therapy adherence.

Policy interventions, reimbursement frameworks, and clinical guidelines now emphasize continuity of oxygen therapy across care settings, prompting manufacturers and providers to reconsider integration across hospital, clinic, and home ecosystems. Stakeholders such as clinicians, procurement officers, and device engineers are balancing clinical efficacy with operational costs and environmental footprint. As a result, technical priorities include reliability under varied ambient conditions, simplified maintenance pathways, and interoperability with remote monitoring systems to enable clinician oversight outside traditional facilities.

Looking forward, the convergence of incremental product innovation, shifting care delivery models, and procurement-driven consolidation is shaping adoption patterns across acute and chronic use. These dynamics underscore the need for robust, evidence-based decision support for clinical teams and supply chain managers evaluating device selection, logistics, and lifecycle management.

How technological miniaturization, digital integration, and shifting distribution models are reconfiguring competitive dynamics and clinical adoption pathways in oxygen delivery

The landscape for oxygen delivery has undergone transformative shifts driven by technological miniaturization, materials improvements, and new service models that emphasize continuity and portability. Advances in pressure swing adsorption modules and membrane materials have improved oxygen purity and energy efficiency, enabling smaller stationary units with lower maintenance burdens and portable concentrators with extended runtimes. These improvements have supported broader adoption of long-term oxygen therapy in home care without compromising clinical safety or patient mobility.

Integration of digital capabilities has also altered the value proposition of devices. Remote monitoring and telehealth interfaces permit clinicians to oversee adherence, detect device faults, and optimize prescriptions based on usage patterns. Simultaneously, distribution channels have diversified: established offline retail and clinical procurement networks remain critical for acute and institutional purchases, while online retail pathways are increasingly important for consumer-directed purchases, spare parts, and consumables. This dual-channel reality has required manufacturers to develop differentiated commercial strategies and after-sales service models.

Regulatory and reimbursement environments are evolving in parallel. Greater emphasis on standardized device performance metrics, cleaning protocols, and supply chain transparency is driving product requalification and upgrades. In response, manufacturers and health systems are piloting bundled service agreements that combine equipment, maintenance, and telemetry. Collectively, these shifts are redefining competitive dynamics and creating opportunities for partnerships that blend device excellence with service reliability.

Assessment of how US tariff adjustments influence sourcing strategies, manufacturing location decisions, and clinical continuity considerations across oxygen delivery supply chains

The introduction and adjustment of tariffs can materially affect component sourcing, manufacturing footprints, and pricing strategies for oxygen delivery equipment. When import duties are applied to key subassemblies or finished devices, manufacturers typically react by assessing alternative sourcing, relocating assembly operations, or absorbing costs while selectively passing increases through to buyers depending on contract terms and competitive pressure. These operational responses can alter lead times for replenishment and reconfigure supplier relationships as procurement teams seek predictable supply at acceptable total cost of ownership.

Tariff changes also have implications for product design and specification choices. Designers may prioritize locally sourced components and modular architectures that allow substitution of affected parts without requiring full redesign. This approach reduces exposure to tariff volatility and supports rapid scaling of production in multiple jurisdictions. In parallel, service providers and distributors reassess inventory positioning and safety stock policies to mitigate the risk of cost spikes and delays originating from cross-border trade disruptions.

Clinically, sudden cost increases or availability constraints can force care providers to modify device mix and utilization strategies, emphasizing reuse and refurbishment pathways where clinically permissible. Regulatory frameworks and procurement contracts that facilitate rapid qualification of alternative suppliers, supported by robust quality assurance and validation records, become critical in maintaining continuity of care. Ultimately, tariffs act as strategic inflection points that accelerate regionalization, influence sourcing ecosystems, and elevate the importance of supply chain resilience planning.

Integrated segmentation insights linking product type, flow characteristics, technological platforms, distribution routes, clinical applications, and end user operational demands

Analyzing demand and deployment patterns requires attention to how different product types and technical features match clinical needs and operational constraints. Oxygen cylinders maintain their essential role in emergency and critical care where high-pressure storage and portability for immediate high-flow requirements are non-negotiable. Stationary concentrators and portable concentrators address different care paradigms: stationary units support continuous oxygen requirements in clinics and multiroom facilities, while portable units enable ambulation and outpatient adherence. Flow characteristics further distinguish device suitability; continuous flow systems are typically preferred for patients requiring steady oxygen delivery, whereas pulse dose devices optimize battery life and size for intermittent breath-by-breath supplementation.

Technology choices also influence procurement and clinical decisions. Membrane-based solutions tend to offer compact, lower-cost options suited to certain portable designs and specific environmental conditions, while pressure swing adsorption platforms are favored for higher purity and scalable stationary applications. Distribution channels affect availability and user experience: offline retail and clinical procurement networks provide direct service, local maintenance, and in-person fitting, whereas online retail increases accessibility for home users and streamlines replenishment of consumables. Applications vary from chronic care contexts where long-term reliability and patient comfort drive specification, to critical care and emergency use where robustness, immediate availability, and compatibility with high-flow systems are paramount. End users span health clinics, home care environments, and hospitals, each imposing distinct operational, training, and maintenance expectations that influence device selection and lifecycle planning.

Regional perspectives on infrastructure readiness, regulatory expectations, and supply chain adaptation shaping device selection and service delivery across major global markets

Regional dynamics determine regulatory frameworks, reimbursement practices, and supply chain architectures that collectively shape product availability and procurement behavior. In the Americas, established clinical standards and extensive home health infrastructures support broad uptake of both stationary and portable concentrators, while logistics networks and service providers emphasize fast response times and warranty coverage. Trade policies and domestic manufacturing incentives influence supplier strategies, and urban-rural disparities in access continue to drive innovation in ruggedized portable solutions.

Europe, the Middle East and Africa present a heterogeneous landscape where regulatory convergence in some markets coexists with fragmented procurement systems in others. European markets often demand certified performance and detailed post-market surveillance, influencing product design and documentation workflows. In parts of the Middle East and Africa, infrastructure variability and climatic extremes necessitate devices designed for high-temperature operation, simplified maintenance, and extended service intervals. Distribution models here often combine institutional procurement for hospitals with NGO or government-led programs to expand access in underserved areas.

Asia-Pacific is characterized by rapid adoption of home-based care models, sizeable manufacturing capabilities, and diverse regulatory regimes. Local production hubs and component suppliers enable regional supply chain flexibility, but varying quality standards and price sensitivity require manufacturers to offer tiered product families. Across all regions, cross-border cooperation on standards and shared learnings about remote patient monitoring, training, and servicing can accelerate safe, scalable adoption of oxygen delivery technologies and improve continuity of care.

Competitive and supplier landscape trends emphasizing service-integrated offerings, supply chain diversification, and specialization in components and niche device capabilities

Leading firms and innovative challengers are investing in product differentiation through improved energy efficiency, noise reduction, and enhanced user interfaces that simplify maintenance and clinician oversight. Strategic partnerships between device manufacturers and service providers are becoming more prevalent, combining equipment supply with telemetry-enabled maintenance contracts and consumable replenishment programs. This shift toward outcome-oriented commercial models reflects a broader industry trend: buyers increasingly value predictable uptime and total lifecycle support over one-time capital pricing alone.

OEMs are also pursuing supply chain diversification and nearshoring to reduce exposure to trade shocks and tariff changes. At the same time, specialized component suppliers focusing on sieve beds, compressors, and battery systems are capturing attention due to their role in device reliability and cost structure. Companies that offer modular designs facilitating rapid field repair, spare parts availability, and robust technical documentation secure competitive advantages, particularly when servicing dispersed home care populations.

Additionally, smaller firms with strong niche capabilities-such as ultra-compact portable units or devices optimized for extreme climates-are carving out sustainable positions by addressing unmet clinical and operational needs. Mergers, licensing agreements, and cross-industry collaborations with telehealth platforms continue to reshape competitive boundaries and create new service-oriented value propositions.

Actionable strategies for executives to strengthen product adaptability, regional supply resilience, hybrid distribution effectiveness, and clinician-focused service models

Industry leaders should prioritize multi-dimensional resilience strategies that balance product innovation with pragmatic supply chain risk management. First, accelerate product modularity and design-for-substitution practices that allow rapid replacement of tariff-affected components while preserving regulatory compliance and clinical performance. Second, invest in trusted local partnerships and regional assembly capabilities to shorten lead times and reduce exposure to cross-border disruptions. Third, embed remote monitoring capabilities and predictive maintenance tools into new device generations to improve uptime and create service revenue streams that offset capital pressures.

Operationally, companies should formalize inventory strategies that combine localized safety stocks with dynamic replenishment algorithms informed by usage telemetry and seasonality patterns. Commercial teams must refine channel strategies to harmonize offline clinical procurement with online retail experiences and to provide consistent after-sales support regardless of purchase route. Engagement with regulators and payers is also vital: proactive collaboration on performance standards, cleaning protocols, and reimbursement pathways will reduce friction during adoption and enhance clinical confidence.

Finally, develop targeted clinical education and training programs that accelerate correct device use and maintenance at the point of care. These programs should be adaptable for hospitals, clinics and home care contexts, and they should leverage digital modalities to scale reach while maintaining quality assurance through competency assessments and certified trainer networks.

Description of the mixed-method research approach combining primary field interviews, device performance observations, regulatory analysis, and scenario-based validation

The research methodology for this study combined qualitative and quantitative approaches to ensure a robust, triangulated evidence base while respecting confidentiality constraints of commercial participants. Primary research included structured interviews with clinicians, procurement officers, device engineers, and supply chain managers across hospitals, clinics, and home care providers to capture operational realities, clinical priorities, and procurement decision triggers. Field visits and device performance observations supplemented interview insights, enabling validation of claims regarding uptime, maintenance frequency, and user ergonomics.

Secondary research incorporated authoritative regulatory documents, technical standards, and product specifications to map device classification, performance criteria, and compliance pathways. Component and materials analysis informed discussions on manufacturing feasibility and substitution strategies. Synthesis of these inputs produced thematic findings around technology adoption, channel evolution, and supply chain risk, while a cross-validation step ensured that recommendations aligned with practitioner expectations and real-world constraints.

Where appropriate, sensitivity checks and scenario analyses were performed to explore operational impacts under different supply chain and policy conditions. Throughout the process, data integrity and transparency were maintained through careful documentation of sources, anonymized excerpts from interviews, and clear delineation between observed facts and expert interpretation.

Concise conclusion synthesizing technology adoption, supply resilience, and collaborative imperatives required to sustain reliable oxygen delivery across care environments

In summary, the oxygen delivery sector is at an inflection point where incremental technology advances intersect with changing care paradigms and supply chain realities. Devices that combine clinical reliability, energy efficiency, and remote management capabilities are positioned to meet the rising demand for continuity of care across hospitals, clinics and home settings. Distribution strategies that balance strong local service networks with accessible online fulfillment enhance reach while preserving quality of support.

Supply chain resilience, including component diversification and nearshoring options, has become a strategic imperative in the face of trade policy changes and logistical uncertainties. Manufacturers and providers that proactively design for substitution, prioritize modularity, and invest in maintenance ecosystems will better sustain uptime and clinical trust. Finally, collaborative engagement among device makers, clinicians, payers and regulators will accelerate safe adoption and ensure that oxygen delivery solutions meet both clinical needs and operational constraints across diverse regions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Product Type

  • 8.1. Oxygen Cylinders
  • 8.2. Portable Medical Oxygen Concentrators & Oxygen Cylinders
  • 8.3. Stationary Medical Oxygen Concentrators & Oxygen Cylinders

9. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Flow Type

  • 9.1. Continuous Flow
  • 9.2. Pulse Dose

10. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Technology

  • 10.1. Membrane Technology
  • 10.2. Pressure Swing Adsorption

11. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Application

  • 11.1. Chronic Care
  • 11.2. Critical Care
  • 11.3. Emergency Use

12. Medical Oxygen Concentrators & Oxygen Cylinders Market, by End User

  • 12.1. Health Clinics
  • 12.2. Home Care
  • 12.3. Hospitals

13. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Distribution Channel

  • 13.1. Offline Retail
  • 13.2. Online Retail

14. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Oxygen Concentrators & Oxygen Cylinders Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Oxygen Concentrators & Oxygen Cylinders Market

18. China Medical Oxygen Concentrators & Oxygen Cylinders Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Air Products Inc.
  • 19.6. AMS Composite Cylinders
  • 19.7. ARYA BioMed Corp.
  • 19.8. Caire Inc. by Niterra Group
  • 19.9. Chaban Medical Ltd.
  • 19.10. Cobham Limited
  • 19.11. DeVilbiss Healthcare GmbH
  • 19.12. GCE Group AB
  • 19.13. GPC Medical Ltd.
  • 19.14. GVS S.p.A.
  • 19.15. Inogen Inc.
  • 19.16. Invacare Corporation
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Linde PLC
  • 19.19. Luxfer Gas Cylinders
  • 19.20. Microteck Systems & Solution
  • 19.21. Narang Medical Limited
  • 19.22. Nidek Medical Products, Inc.
  • 19.23. O2 Concepts, LLC
  • 19.24. OxyGo, LLC
  • 19.25. OxyMed
  • 19.26. ResMed Inc.
  • 19.27. Silverline Meditech Pvt. Ltd.
  • 19.28. VARON
  • 19.29. VitalAire Canada Inc.
  • 19.30. WEINMANN Emergency Medical Technology GmbH + Co. KG
  • 19.31. Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY OXYGEN CYLINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY OXYGEN CYLINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY OXYGEN CYLINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PORTABLE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PORTABLE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PORTABLE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY STATIONARY MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY STATIONARY MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY STATIONARY MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PULSE DOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PULSE DOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PULSE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CHRONIC CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CHRONIC CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CHRONIC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY EMERGENCY USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY EMERGENCY USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY EMERGENCY USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HEALTH CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HEALTH CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HEALTH CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA MEDICAL OXYGEN CONCENTRATORS & OXYGEN CYLINDERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)